AtaiBeckley (ATAI) Short term Debt (2021 - 2026)
AtaiBeckley (ATAI) recorded quarterly Short term Debt of $310000.0 in Q1 2026, up 14.39% quarter-over-quarter from $271000.0 in Q4 2025.
AtaiBeckley (ATAI) Short term Debt (2021 - 2026) Analysis & Trends
AtaiBeckley's Short term Debt history runs 3 years deep, the most recent figure standing at $310000.0 for Q1 2026.
- In Q1 2026, Short term Debt changed N/A year-over-year to $310000.0; the TTM figure through Mar 2026 stood at $310000.0 (changed N/A YoY), while the FY2025 annual figure was $271000.0, down 95.75% from the prior year.
- Short term Debt was $310000.0 for Q1 2026 at AtaiBeckley, up from $271000.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $132.5 million in Q3 2023 to a low of $38000.0 in Q3 2021.
- The 5-year median for Short term Debt is $212000.0 (2022), against an average of $18.1 million.
- Biggest YoY gain for Short term Debt was 95.75% in 2025; the steepest drop was 95.75% in 2025.
- A 3-year view of Short term Debt shows it stood at $6.4 million in 2024, then sank by 95.75% to $271000.0 in 2025, then increased by 14.39% to $310000.0 in 2026.
- The last three Short term Debt figures came in at $310000.0 (Q1 2026), $271000.0 (Q4 2025), and $6.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310,000.00 |
| Dec 31, 2025 | 271,000.00 |
| Mar 31, 2025 | 11.37 Mn |
| Dec 31, 2024 | 477,000.00 |
| Dec 31, 2024 | 6.37 Mn |
| Mar 31, 2024 | 244,000.00 |
| Sep 30, 2023 | 132.50 Mn |
| Dec 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 38,000.00 |
| Jun 30, 2021 | 39,000.00 |